These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1633728)

  • 41. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
    Sasaki K; Murakami T; Ogino T; Takahashi M
    Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
    Webster L; Hodgkiss RJ; Wilson GD
    Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA.
    Endresen PC; Prytz PS; Aarbakke J
    Cytometry; 1995 Jun; 20(2):162-71. PubMed ID: 7545098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Flow cytometric bromodeoxyuridine (BrdU)/DNA analysis--study with urogenital tumors].
    Shimabukuro T; Yoshihiro S; Matsuyama H; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1989 Oct; 35(10):1653-7. PubMed ID: 2610171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
    Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
    Jensen PO; Larsen JK; Christensen IJ; van Erp PE
    Cytometry; 1994 Feb; 15(2):154-61. PubMed ID: 8168402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokinetic properties of asynchronous and cytosine arabinoside perturbed murine tumors measured by simultaneous bromodeoxyuridine/DNA analyses.
    Pallavicini MG; Summers LJ; Dolbeare FD; Gray JW
    Cytometry; 1985 Nov; 6(6):602-10. PubMed ID: 4064840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
    Baisch H; Otto U; Hatje U; Fack H
    Cytometry; 1995 Sep; 21(1):52-61. PubMed ID: 8529471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements.
    Gong J; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Nov; 53(21):5096-9. PubMed ID: 8221643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring potential doubling times of murine tumors using flow cytometry.
    Carlton JC; Terry NH; White RA
    Cytometry; 1991; 12(7):645-50. PubMed ID: 1782833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S-phase arrest of nutrient deprived lung cancer cells.
    Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
    Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative flow cytometric analysis of DNA-bound PCNA and DNA content as estimators of S-phase cells in cell cultures.
    Bustamante AS; Guervós MA; de los Toyos JR; Dolbeare F; Sampedro A
    Anal Cell Pathol; 1996 Jul; 11(2):127-36. PubMed ID: 8844110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
    Perras JP; Ramos R; Sevin BU
    Cytometry; 1993; 14(4):441-8. PubMed ID: 8513698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of bromodeoxyuridine incorporation by alteration of the fluorescence emission from nucleic acid binding dyes using only an argon ion laser.
    Frey T
    Cytometry; 1994 Dec; 17(4):310-8. PubMed ID: 7875038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferation behavior of xenografted human tumors: a flow cytometric study.
    Köpf-Maier P; Jäckel M
    Anticancer Res; 1988; 8(6):1355-60. PubMed ID: 3218968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of sampling time on assessment of potential doubling time.
    Høyer M; Bentzen SM; Salling LN; Overgaard J
    Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA.
    Cheitlin RA; Bodell WJ
    Anticancer Res; 1988; 8(3):471-4. PubMed ID: 3389750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using monoclonal antibodies in bromodeoxyuridine-DNA analysis.
    Dolbeare F; Kuo WL; Beisker W; Vanderlaan M; Gray JW
    Methods Cell Biol; 1990; 33():207-16. PubMed ID: 1707484
    [No Abstract]   [Full Text] [Related]  

  • 59. Flow cytometric detection of chromosome abnormalities by measuring centromeric index, DNA content, and DNA base composition.
    Rens W; Boschman GA; Hoovers JM; Manders EM; Slater RM; Stap J; Aten JA
    Anal Cell Pathol; 1994 May; 6(4):359-75. PubMed ID: 8060891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BrdUrd incorporation studies for evaluation of spermatogenesis in the blue fox.
    Clausen OP; Berg KA; Kirkhus B; De Angelis P; Huitfeldt H
    Cytometry; 1992; 13(4):374-80. PubMed ID: 1526196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.